Changes of clotting factors (7, 9 and 10) and hepatocyte growth factor in patients with thrombotic microangiopathy after bone marrow transplantation

Clinical Transplantation

Volumn 20, Issue 5, 2006, Pages 640-643

  Takatsuka, Hiroyuki ^a   Nakajima, Toshiyuki ^a   Nomura, Kaori ^a   Okikawa, Yoshiko ^a   Wakae, Takeshi ^a   Toda, Akinari ^a   Itoi, Hisayuki ^a   Okada, Masaya ^a   Misawa, Mahito ^a   Hara, Hiroshi ^a   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Clotting factor; Hepatocyte growth factor; Thrombotic microangiopathy

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; SCATTER FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LIVER DYSFUNCTION; LYMPHOBLASTOMA; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK ASSESSMENT; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

ADULT; BONE MARROW TRANSPLANTATION; FACTOR IX; FACTOR VII; FACTOR X; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER DISEASES; MALE; POSTOPERATIVE COMPLICATIONS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 33748640361     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00530.x     Document Type: Article

References (17)

1. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994: 14: 495.
2. Kakishita E. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS). Int J Hematol 2000: 71: 320.
3. Furlan M, Robles R, Solenthaler M, Wassmer M, Sondoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997: 89: 3097.
4. Fujikawa K, Suzuki H, Mc Mullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001: 98: 1662.
5. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem (2001) 2001: 41059.
6. van der Plas RM, Schiphorst ME, Huizinga EG et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999: 93: 3798.
7. Takatsuka H, Takemoto Y, Okamoto T et al. Thrombotic microangiopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 1999: 24: 303.
8. Takatsuka H, Wakae T, Mori A et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation. Bone Marrow Transplant 2002: 29: 907.
9. Takatsuka H, Wakae T, Mori A et al. Effects of total irradiation on the vascular endothelium. Clin Transplant 2002: 16: 374.
10. Takatsuka H, Wakae T, Mori A et al. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 2003: 31: 475.
11. Takatsuka H, Wakae T, Toda A et al. Association of Helicobacter pylori with thrombotic thrombocytopenic purpura hemolytic uremic syndrome after bone marrow transplantation. Clin Transplant 2004: 18: 547.
12. Takatsuka H, Nakajima T, Nomura K et al. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation. Clin Transplant 2005: 19: 418.
13. Takatsuka H, Nakajima T, Nomura K et al. Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation. Hematology 2006: 11: 101.
14. Moschowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch Intern Med 1924: 1: 89.
15. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor serum of hepatectomized rats. Biochem Biophys Res Commun 1984: 122: 1450.
16. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992: 16: 1227.
17. Michalopoulous GK, De Frances MC. Liver regeneration. Science 1997: 276: 60.